Abstract:Medical progress has historically depended on scientific discoveries. Until recently, science was driven by technological advancements that, once translated to the clinic, fostered new treatments and interventions. More recently, technology-driven medical progress has often outpaced laboratory research. For example, intravascular devices, pacemakers for the heart and brain, spinal cord stimulators, and surgical robots are used routinely to treat a variety of diseases. The rapid expansion of science into ever more advanced molecular and genetic mechanisms of disease has often distanced laboratory-based research from day-to-day clinical realities that remain based on evidence and outcomes. A recognized reason for this hiatus is the lack of laboratory tools that recapitulate the clinical reality faced by physicians and surgeons. To overcome this, the NIH and FDA have in the recent past joined forces to support the development of a "human-on-a-chip" that will allow research scientists to perform experiments on a realistic replica when testing the effectiveness of novel experimental therapies. The development of a "human-on-a-chip" rests on the capacity to grow in vitro various organs-on-a-chip, connected with appropriate vascular supplies and nerves, and our ability to measure and perform experiments on these virtually invisible organs. One of the tissue structures to be scaled down on a chip is the human blood-brain barrier. This review gives a historical perspective on in vitro models of the BBB and summarizes the most recent 3D models that attempt to fill the gap between research modeling and patient care. We also present a summary of how these in vitro models of the BBB can be applied to study human brain diseases and their treatments. We have chosen NeuroAIDS, COVID-19, multiple sclerosis, and Alzheimer's disease as examples of in vitro model application to neurological disorders. Major insight pertaining to these illnesses as a consequence of more profound understanding of the BBB can reveal new avenues for the development of diagnostics, more efficient therapies, and definitive clarity of disease etiology and pathological progression.

Human Brain In Vitro Model for Pathogen Infection-Related Neurodegeneration Study

Engineering Three-Dimensional Microenvironments Towards in Vitro Disease Models of the Central Nervous System

iPSC-derived three-dimensional brain organoid models and neurotropic viral infections

Tissue-Engineered Models of the Human Brain: State-of-the-Art Analysis and Challenges

In vitro Models of the Blood-Brain Barrier: Tools in Translational Medicine

Neuroinflammatory in Vitro Cell Culture Models and the Potential Applications for Neurological Disorders.

Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting

Using 2D and 3D pluripotent stem cell models to study neurotropic viruses

Recent progresses in novel in vitro models of primary neurons: A biomaterial perspective

In vitro engineered models of neurodegenerative diseases

Human cerebral organoids — a new tool for clinical neurology research

Unlocking Neural Function with 3D In Vitro Models: A Technical Review of Self-Assembled, Guided, and Bioprinted Brain Organoids and Their Applications in the Study of Neurodevelopmental and Neurodegenerative Disorders

The Evolution of Technology‐Driven In Vitro Models for Neurodegenerative Diseases

Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through

Modeling brain development and diseases with human cerebral organoids

Organotypic culture of human brain explants as a preclinical model for AI-driven antiviral studies

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: from 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

In vitro modelling of the neurovascular unit for ischemic stroke research: Emphasis on human cell applications and 3D model design

Human 3D brain organoids: steering the demolecularization of brain and neurological diseases

Advancements in organs-on-chips technology for viral disease and anti-viral research

Brain organoids: A new tool for modelling of neurodevelopmental disorders